The effect of sleep and wake training on anxiety, depression and some related hormones in infertile wome

Not Applicable

• Conditions: physical and mental health.

• Registration Number: IRCT20140622018187N8
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 March 2020

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 130

Inclusion Criteria

Poor sleep quality (greater than or equal to 5) based on the Pittsburgh questionnaire, mild depression (score less than 18) based on the Beck Depression Inventory and mild anxiety (score less than 15) based on the Beck Anxiety Inventory.
Have been referred to the Infertility Center of Hazrat Zeinab Hospital for infertility treatment.
Have informed consent to participate in the research and complete the relevant form
Absence of mental and mental illnesses to the diagnosis of the relevant physician
Absence of internal diseases to the doctor's diagnosis
Absence of internal diseases to the doctor's diagnosis
No stressful or disturbing event has occurred in the last 6 months
Unusual situations such as traveling, changing jobs and having stressful jobs, shifting diets, and the like over the last 3 months that have caused a change in sleep patterns
Not taking hormone drugs at least 4-6 weeks before blood sampling
Abnormal bleeding or amenorrhea in a way that there is no possibility of bleeding on the third day of the menstrual cycle.

Exclusion Criteria

Patient dissatisfaction with continuing to participate in research at each stage
Incidence of each of the 4 to 10 items listed in the inclusion criteria in each research step
Pregnancy at each stage of research

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood hormones (TSH, FSH, LH, PROLACTIN) will be measured on day 3 of the menstrual cycle. Timepoint: Blood sampling at baseline and then 6 months after the last intervention. Method of measurement: Blood sampling and hormonal testing.

Secondary Outcome Measures

Name	Time	Method
Mental health. Timepoint: At the beginning of the study and 1 month and 6 months after the end of the intervention. Method of measurement: - Pittsburgh PSQI questionnaire- Beck Depression Inventory (BDI)- BAI Anxiety Inventory- Demographic questionnaire (including information on age, education, occupation and couple, history of infertility by type and cause, socioeconomic status, body mass index, distance from previous pregnancy (if secondary), medication use, smoking, alcohol and Tobacco and Paraclinical Tests and Records)Depression Inventory and Mild Anxiety (score less than 15) based on Beck Anxiety Inventory.